- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 20-F Annual report (foreign)
- 8 Subsidiaries of the Registrant
- 10 Consent of Kesselman & Kesselman
- 12 Certification of the Chief Executive Officer Pursuant to Section 302
- 12 Certification of the Chief Financial Officer Pursuant to Section 302
- 13 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
Exhibit 10
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333–178400 and No. 333-131387) and on Form S-8 (No. 333-168331) of Teva Pharmaceutical Industries Limited of our report dated February 17, 2012 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to the incorporation by reference of our report dated February 17, 2012 relating to the Financial Statement Schedule, which appears in this Form 20-F.
Tel-Aviv, Israel February 17, 2012 | /s/ Kesselman & Kesselman Certified Public Accountants (Isr.) A member of PricewaterhouseCoopers International Limited |